These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Immunobiological properties of Bordetella pertussis lipopolysaccharide in the acellular pertussis vaccine]. Zaĭtsev EM; Poddubikov AV; Britsina MV; Mertsalova NU; Ozeretskovskaia MN; Bazhanova IG; Plekhanova NG Zh Mikrobiol Epidemiol Immunobiol; 2014; (1):20-4. PubMed ID: 24738289 [TBL] [Abstract][Full Text] [Related]
7. Quantification of cell-associated and free antigens in Bordetella pertussis suspensions by antigen binding ELISA. Westdijk J; van den Ijssel J; Thalen M; Beuvery C; Jiskoot W J Immunoassay; 1997 Aug; 18(3):267-84. PubMed ID: 9257265 [TBL] [Abstract][Full Text] [Related]
8. [Physicochemical and immunobiological properties of the dialysate antigen of Bordetella pertussis]. Iagovkina VV; Moskalenko EP Zh Mikrobiol Epidemiol Immunobiol; 1987 Dec; (12):11-5. PubMed ID: 2895557 [TBL] [Abstract][Full Text] [Related]
9. Proliferative responses to purified and fractionated Bordetella pertussis antigens in mice immunized with whole-cell pertussis vaccine. Petersen JW; Andersen P; Ibsen PH; Capiau C; Wachmann CH; Hasløv K; Heron I Vaccine; 1993; 11(4):463-72. PubMed ID: 8470432 [TBL] [Abstract][Full Text] [Related]
10. [Improved technology of culturing Bordetella pertussis based on a study of the kinetics of the process]. Miriasova LV; Basnak'ian IA Zh Mikrobiol Epidemiol Immunobiol; 1983 Oct; (10):20-5. PubMed ID: 6318479 [TBL] [Abstract][Full Text] [Related]
11. Proteome Analysis Is a Valuable Tool to Monitor Antigen Expression during Upstream Processing of Whole-Cell Pertussis Vaccines. Metz B; Hoonakker M; Uittenbogaard JP; Weyts M; Mommen GP; Meiring HD; Tilstra W; Pennings JL; van der Pol LA; Kuipers B; Sloots A; van den IJssel J; van de Waterbeemd B; van der Ark A J Proteome Res; 2017 Feb; 16(2):528-537. PubMed ID: 27977922 [TBL] [Abstract][Full Text] [Related]
12. [A comparative analysis of the antigenic complexes isolated from synthetic and semisynthetic media for the cultivation of Bordetella pertussis]. Semina IE; Bazhanova IG; Melikhov VI; Chechot VA; Mileĭkovskaia MM; Mertsalova NU; Shmeleva EI; Remova TN; Sukhinova EE; Ozeretskovskaia MN Zh Mikrobiol Epidemiol Immunobiol; 1995; (2):87-92. PubMed ID: 7653146 [TBL] [Abstract][Full Text] [Related]
13. [The development of a process for culturing Bordetella pertussis immobilized on a polyurethane carrier]. Miriasova LV; Basnak'ian IA; Kopaeva TV; Sarkisov IIu Zh Mikrobiol Epidemiol Immunobiol; 1999; (3):6-9. PubMed ID: 10851980 [TBL] [Abstract][Full Text] [Related]
14. Role of pertussigen (pertussis toxin) on the mouse protective activity of vaccines made from Bordetella species. Munoz JJ; Peacock MG Microbiol Immunol; 1989; 33(4):341-55. PubMed ID: 2549344 [TBL] [Abstract][Full Text] [Related]
15. [Use of an immunoblotting method for identifying the individual proteins in the antigenic complexes of Bordetella pertussis]. Semina IE; Iankina ZK Zh Mikrobiol Epidemiol Immunobiol; 1989 Mar; (3):78-81. PubMed ID: 2568040 [TBL] [Abstract][Full Text] [Related]
16. Immunogenicity and protective efficacy of a recombinant filamentous haemagglutinin from Bordetella pertussis. Knight JB; Huang YY; Halperin SA; Anderson R; Morris A; Macmillan A; Jones T; Burt DS; Van Nest G; Lee SF Clin Exp Immunol; 2006 Jun; 144(3):543-51. PubMed ID: 16734625 [TBL] [Abstract][Full Text] [Related]
19. Further contributions to an improved pertussis vaccine: II. New findings in the development of a pertussis vaccine. Robbel L; Hungerer KD; Aktories K Behring Inst Mitt; 1984 Nov; (76):110-2. PubMed ID: 6098261 [No Abstract] [Full Text] [Related]
20. Effect of hydromechanical stress on cellular antigens of Bordetella pertussis. Rodriguez ME; Hozbor DF; Yantorno OM J Ind Microbiol; 1996 Jul; 17(1):53-5. PubMed ID: 8987690 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]